Literature DB >> 7883212

Satiety effects of a physiological dose of cholecystokinin in humans.

R J Lieverse1, J B Jansen, A A Masclee, C B Lamers.   

Abstract

Cholecystokinin 33 (CCK) was infused intravenously to eight healthy obese women and 10 healthy lean women of the same age, in doses that elicited plasma cholecystokinin concentrations in the physiological range. The effect of these infusions after a standardised banana 'shake' (preload) on food intake and satiety signals was compared with the effect of saline infusions in the same subjects. For the whole group food intake (mean (SEM)) (282 (29 g)) was significantly less during CCK than during saline (346 (31) g, p < 0.05). Hunger feelings tended to be less during CCK infusions. Examination of the separate subgroups showed no differences between lean and obese subjects in the satiety effects of CCK. In conclusion, under the conditions of this study, CCK significantly decreases food intake in humans, and this effect is similar for lean and obese subjects.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7883212      PMCID: PMC1382399          DOI: 10.1136/gut.36.2.176

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  22 in total

1.  Hunger in humans induced by MK-329, a specific peripheral-type cholecystokinin receptor antagonist.

Authors:  O M Wolkowitz; B Gertz; H Weingartner; L Beccaria; K Thompson; R A Liddle
Journal:  Biol Psychiatry       Date:  1990-07-15       Impact factor: 13.382

2.  Gastric loads potentiate inhibition of food intake produced by a cholecystokinin analogue.

Authors:  G J Schwartz; L A Netterville; P R McHugh; T H Moran
Journal:  Am J Physiol       Date:  1991-11

3.  Plasma CCK levels after food intake and infusion of CCK analogues that inhibit feeding in dogs.

Authors:  R D Reidelberger; T J Kalogeris; T E Solomon
Journal:  Am J Physiol       Date:  1989-05

4.  Cholecystokinin octapeptide decreases intake of solid food in man.

Authors:  G Stacher; H Steinringer; G Schmierer; C Schneider; S Winklehner
Journal:  Peptides       Date:  1982 Mar-Apr       Impact factor: 3.750

5.  Inconsistency and possible habituation of CCK-induced satiety.

Authors:  S Mineka; C T Snowdon
Journal:  Physiol Behav       Date:  1978-07

6.  C-terminal octapeptide of cholecystokinin decreases food intake in obese men.

Authors:  X Pi-Sunyer; H R Kissileff; J Thornton; G P Smith
Journal:  Physiol Behav       Date:  1982-10

7.  Effect of a low dose of intraduodenal fat on satiety in humans: studies using the type A cholecystokinin receptor antagonist loxiglumide.

Authors:  R J Lieverse; J B Jansen; A A Masclee; L C Rovati; C B Lamers
Journal:  Gut       Date:  1994-04       Impact factor: 23.059

8.  C-terminal octapeptide of cholecystokinin decreases food intake in man.

Authors:  H R Kissileff; F X Pi-Sunyer; J Thornton; G P Smith
Journal:  Am J Clin Nutr       Date:  1981-02       Impact factor: 7.045

Review 9.  Cholecystokinin and satiation.

Authors:  R J Lieverse; J B Jansen; C B Lamers
Journal:  Neth J Med       Date:  1993-04       Impact factor: 1.422

10.  Rapid development of tolerance to the behavioural actions of cholecystokinin.

Authors:  J N Crawley; M C Beinfeld
Journal:  Nature       Date:  1983-04-21       Impact factor: 49.962

View more
  21 in total

Review 1.  Gut hormones as potential new targets for appetite regulation and the treatment of obesity.

Authors:  Benjamin C T Field; Alison M Wren; Dunstan Cooke; Stephen R Bloom
Journal:  Drugs       Date:  2008       Impact factor: 9.546

Review 2.  Central control of body weight and appetite.

Authors:  Stephen C Woods; David A D'Alessio
Journal:  J Clin Endocrinol Metab       Date:  2008-11       Impact factor: 5.958

Review 3.  Obesity treatment: novel peripheral targets.

Authors:  Benjamin C T Field; Owais B Chaudhri; Stephen R Bloom
Journal:  Br J Clin Pharmacol       Date:  2009-12       Impact factor: 4.335

Review 4.  Controversies surrounding high-protein diet intake: satiating effect and kidney and bone health.

Authors:  Marta Cuenca-Sánchez; Diana Navas-Carrillo; Esteban Orenes-Piñero
Journal:  Adv Nutr       Date:  2015-05-15       Impact factor: 8.701

Review 5.  Development of minimally invasive techniques for management of medically-complicated obesity.

Authors:  Farzin Rashti; Ekta Gupta; Suzan Ebrahimi; Timothy R Shope; Timothy R Koch; Christopher J Gostout
Journal:  World J Gastroenterol       Date:  2014-10-07       Impact factor: 5.742

Review 6.  Ghrelin, CCK, GLP-1, and PYY(3-36): Secretory Controls and Physiological Roles in Eating and Glycemia in Health, Obesity, and After RYGB.

Authors:  Robert E Steinert; Christine Feinle-Bisset; Lori Asarian; Michael Horowitz; Christoph Beglinger; Nori Geary
Journal:  Physiol Rev       Date:  2017-01       Impact factor: 37.312

Review 7.  Regulating satiety in bulimia nervosa: the role of cholecystokinin.

Authors:  Sandy Hannon-Engel
Journal:  Perspect Psychiatr Care       Date:  2011-04-13       Impact factor: 2.186

Review 8.  The gut and food intake: an update for surgeons.

Authors:  E Näslund; P M Hellström; J G Kral
Journal:  J Gastrointest Surg       Date:  2001 Sep-Oct       Impact factor: 3.452

Review 9.  Metabolic surgery-principles and current concepts.

Authors:  M Gass; C Beglinger; R Peterli
Journal:  Langenbecks Arch Surg       Date:  2011-08-26       Impact factor: 3.445

10.  Benefits of Sustained Upregulated Unimolecular GLP-1 and CCK Receptor Signalling in Obesity-Diabetes.

Authors:  Neil Tanday; Andrew English; Ryan A Lafferty; Peter R Flatt; Nigel Irwin
Journal:  Front Endocrinol (Lausanne)       Date:  2021-05-14       Impact factor: 5.555

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.